I Nyoman Gede Budiana
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Udayana University
I Nyoman Bayu Mahendra
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Udayana University
I Gde Sastra Winata
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Udayana University
Kade Yudi Saspriyana
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia ; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Udayana University
Kevin Agastya Duarsa
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Pande Made Suwanpramana
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Rayvany Uil
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Putu Pradnya Paramitha Dewi
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Made Yudha Ganesa Wikantyas Widia
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Eric Gradiyanto Ongko
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
I Gede Indra Kumara
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Charles Richard Thene
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Johan Qalaba
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Made Ayu Prabawaty Indraswari
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Ida Bagus Arjuna
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Putu Harrista Indra Pramana
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Ernest T. B. Sianturi
Department of Obstetric and Gynecology, Faculty of Medicine, Udayana University/Prof Dr I GNG Ngoerah Hospital, Indonesia
Keywords
Cervical Cancer, histopathological, parity, stage, under 40 years old
Abstract
Background: Cervical cancer is the main cause of death for women worldwide. 500.000 new cases and 250.000 deaths are reported each year. In Indonesia, women as young as 25 are being diagnosed with this disease. The study will be conducted at Prof.Dr.I.G.N.G Ngoerah Hospital from January to December 2022 to analyze cervical cancer patients under 40. This study aimed to see the profile and the distribution of 40 year-old women with cervical cancer at our hospital.
Methods: This descriptive study was conducted using medical records that were centered around female patients who were below 40 years of age and had been diagnosed with cervical cancer in Prof.Dr.I.G.N.G Ngoerah hospital in January - December 2022. Purposive sampling was done, and the samples were selected according to the inclusion criteria. The resulting data was presented in a table format.
Results: Fifty-one cervical cancer patients aged under 40 years were included, with most of the age group being 30 – 39 years (88.2%). Twenty-eight patients (54.9%) were in the two-to-three parity group. The most dominant stage of cervical cancer is stage IIIB, with a total of 20 people (39.2%). Non-keratinizing squamous cell carcinoma (NKSCC) was the most common histopathological appearance (64.7%).
Conclusions: The study found that cervical cancer commonly affects those between 30-39 years old, particularly in the form of NKSCC. Many patients are diagnosed in advanced stages of the disease. Early screening, education, and vaccination programs are crucial in preventing cervical cancer.
Abstract